William Snider insider trades
Open-market stock purchases and sales by William Snider, Director at Harvard Bioscience Inc, from SEC Form 4 filings since Sep 27, 2010.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +26%.